Article citationsMore>>

M. A. Schnitzler, J. A. Lowell, K. L. Hardinger, S. B. Boxerman, T. C. Bailey and D. C. Brennan, “The Association of Cytomegalovirus Sero-Pairing with Outcomes and Costs Following Cadaveric Renal Transplantation Prior to the Introduction of Oral Ganciclovir CMV Prophylaxis,” American Journal of Transplantation, Vol. 3, No. 4, 2003, 445-451. doi:10.1034/j.1600-6143.2003.00069.x

has been cited by the following article:

• TITLE: A Case of Cytomegalovirus-Induced Arthritis after Lymphocyte-Depleting Therapy for Kidney Allograft Rejection

  AUTHORS: Richard Fuquay, James Eric Cooper

  KEYWORDS: Cytomegalovirus (Mesh); Arthritis (Mesh); Kidney Transplantation (Mesh); Immunosuppression (Mesh); Chemoprevention (Mesh); Valganciclovir (Mesh)

  JOURNAL NAME: Open Journal of Nephrology, Vol.2 No.1, March 28, 2012

  ABSTRACT: Cytomegalovirus viremia and tissue-invasive disease are common after kidney transplantation. Chemoprophylaxis has made substantial improvement in this clinical problem. Here we report a 29-year-old woman who had kidney allograft rejection and received lymphocyte-depleting therapy. She presented with a new oligo-arthritis that led to 2 successive arthrocenteses. The etiology of the inflammation could not be determined initially. On the second arthrocentesis, a synovial fluid cytomegalovirus polymerase chain reaction test was positive. The patient responded to treatment with valganciclovir, had negative follow-up serum cytomegalovirus polymerase chain reaction tests, and experienced resolution of her joint inflammation. We review briefly the data for cytomegalovirus chemoprophylaxis, preemptive screening, and treatment recommendations.